Key result
The use of Custodiol HTK cardioplegia in robotic mitral valve surgery provides effective myocardial protection and reduces operative times by eliminating the need for percutaneous coronary sinus catheter placement.
Why the study?
Does Custodiol HTK cardioplegia improve operative times and reduce costs compared to percutaneous coronary sinus cannulation in robotic mitral valve surgery?
Does Custodiol HTK cardioplegia improve operative times and reduce costs compared to percutaneous coronary sinus cannulation in robotic mitral valve surgery?
Custodiol HTK cardioplegia simplifies myocardial protection in robotic mitral valve surgery by eliminating the need for percutaneous coronary sinus cannulation, potentially reducing operative times and costs.
May simplify robotic mitral valve surgery by avoiding percutaneous cannulation; leaves open whether randomized trials confirm time and cost benefits.
Robotic surgery is a growing subspecialty in cardiac surgery. Custodiol® HTK cardioplegia offers long-term myocardial protection, decreased metabolism, and eliminates multiple cardioplegia dosing. This article reviews the technique, strategy, and considerations for use of Custodiol® HTK for myocardial protection in robotic mitral valve surgery.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2013) conducted a review in Robotic mitral valve surgery. Custodiol HTK cardioplegia was evaluated. The use of Custodiol HTK cardioplegia in robotic mitral valve surgery provides effective myocardial protection and reduces operative times by eliminating the need for percutaneous coronary sinus catheter placement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: